.svg)
You are now leaving Astellas.us. The website you are linking to is neither owned nor controlled by Astellas.
Astellas is not responsible for the content or services on this site.
News Releases
Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
-
Feb 13, 2018Acquisition enables Astellas to fully utilize proprietary technology to produce pluripotent stem cells that have the potential to lower immunological rejection in numerous therapeutic areas
Jan 29, 2018- A total of 10 abstracts and one trial in progress (TIP) across various cancers to be presented during oral and poster sessions --
Jan 23, 2018
